Home » Stocks » NPTX

Neuropathix, Inc (NPTX)

Stock Price: $0.1700 USD 0.0050 (3.03%)
Updated May 7, 2021 3:31 PM EDT - Market closed
Market Cap 14.84M
Revenue (ttm) n/a
Net Income (ttm) -4.54M
Shares Out 87.29M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $0.1700
Previous Close $0.1650
Change ($) 0.0050
Change (%) 3.03%
Day's Open 0.1633
Day's Range 0.1633 - 0.1714
Day's Volume 86,029
52-Week Range 0.1010 - 0.5450

News

Hide News

DOYLESTOWN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today that it...

3 months ago - GlobeNewsWire

DOYLESTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the publicati...

3 months ago - GlobeNewsWire

DOYLESTOWN, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), (the “Company” or "Neuropathix"), a socially responsible pain management life sciences company, announced today that i...

4 months ago - GlobeNewsWire

About NPTX

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary cannabinoid product platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild trauma... [Read more...]

Industry
Biotechnology
Founded
2010
Stock Exchange
OTCMKTS
Ticker Symbol
NPTX
Full Company Profile

Financial Performance

Financial Statements